Renaissance Technologies’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Renaissance Technologies’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-34,460	Closed	-$220K	–	4214
2023 Q4	$220K	Buy	34,460 +8,100	+31%	+$43.4K	﹤0.01%	3104
2023 Q3	$113K	Buy	26,360 +4,500	+21%	+$17.8K	﹤0.01%	3221
2023 Q2	$56K	Buy	21,860 +6,487	+42%	+$25.6K	﹤0.01%	3592
2023 Q1	$105K	Buy	15,373 +2,280	+17%	+$17.7K	﹤0.01%	3482
2022 Q4	$93K	Sell	13,093 -1,174	-8%	-$11.2K	﹤0.01%	3646
2022 Q3	$150K	Sell	14,267 -3,415	-19%	-$44.4K	﹤0.01%	3480
2022 Q2	$231K	Sell	17,682 -12,079	-41%	-$155K	﹤0.01%	3583
2022 Q1	$500K	Buy	29,761 +15,754	+112%	+$292K	﹤0.01%	3196
2021 Q4	$416K	Buy	14,007 +1,040	+8%	+$42.5K	﹤0.01%	3166
2021 Q3	$663K	Buy	+12,967	New	+$922K	﹤0.01%	2768

Renaissance Technologies's FRLN Position: Q1 2024 in Review

Renaissance Technologies sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2024, closing a stake of 34,460 shares — an estimated $220K sold.

Renaissance Technologies first reported a position in FRLN in Q3 2021 and held it in 10 quarters. The position peaked at $663K in Q3 2021. 0 funds tracked by Wall St. Rank hold FRLN as of Q1 2024.

Renaissance Technologies reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Renaissance Technologies sold 34,460 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2024, an estimated $220K.
Renaissance Technologies first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2021 and held it in 10 quarters.
Renaissance Technologies's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $663K in Q3 2021.
0 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.